For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260430:nRSd5999Ca&default-theme=true
RNS Number : 5999C Kazera Global PLC 30 April 2026
The information contained within this announcement is deemed by the Company to
constitute inside information as stipulated under the Market Abuse Regulation
(EU) No. 596/2014 as it forms part of United Kingdom domestic law by virtue of
the European Union (Withdrawal) Act 2018, as amended by virtue of the Market
Abuse (Amendment) (EU Exit) Regulations 2019.
30 April 2026
Kazera Global plc
("Kazera" or the "Company")
Funding Update: Loan Facility Extension and Increase
Kazera Global plc (AIM: KZG), the AIM-quoted investment company is pleased to
announce that it has agreed with Richard Jennings (the "Lender") to extend and
increase the unsecured loan facility originally entered into in August 2024
(the "Loan Agreement"), as detailed in an RNS dated 9 August 2024 and
subsequently varied on 28 October 2025.
Under the Loan Agreement (as previously varied), the loan was due for
repayment on or before 30 April 2026 (the "Existing Loan"). The Company and
the Lender have agreed, pursuant to a second variation agreement, to extend
the repayment date to 1 December 2026 and to increase the total amount
available to the Company by up to £500,000, in order to provide continued
financial flexibility as the Company advances its operations (the "New
Facility").
The total amount outstanding under the Existing Loan prior to the loan
extension, was £187,880 ("Loan Balance").
The Company remains in discussions with Tracarta Limited, a separate lender to
the Company, in respect of its loan facility, pursuant to which, £436,128 is
due to mature on 30 April 2026.
Revised Terms
The principal revised terms of the Loan Agreement (as further varied) are as
follows:
· Term: Extended from 30 April 2026 to 1 December 2026.
· Increase in Facility: The total facility available to the Company has
been increased by up to £500,000 through the provision of an additional
unsecured term loan facility under the Loan Agreement (as varied).
· Drawdown: The New Facility is expected to be drawn in tranches,
including £50,000 on or around 1 May 2026 and £50,000 on or around 1 June
2026, with further drawdowns at such times and in such amounts as may be
mutually agreed in writing between the parties, subject to the aggregate limit
of £500,000.
· Lender Discretion: The Lender's obligation to advance any tranche
beyond the initial drawdown is subject to the Lender being satisfied, in its
sole discretion, as to the Company's capacity to repay amounts outstanding
under the Loan Agreement.
· Interest and Fees: Fixed interest of £18,788 (being 10% of the Loan
Balance), plus an amount equal to 10% of the additional amount drawn under the
New Facility.
· Repayment: All amounts outstanding under the Loan Agreement, together
with any amounts drawn under the New Facility and associated charges, will be
repayable on 1 December 2026.
All other terms of the Loan Agreement remain unchanged.
The Board believes that the extension and increase of the facility from
Richard Jennings provides the Company with additional financial flexibility as
it continues to progress its operational priorities and engage constructively
with its other lender, Tracarta Limited.
Further updates will be provided as appropriate.
Geoff Eyre, Non-Executive Chairman of Kazera, commented: "We are very pleased
to have secured this additional funding support from our CEO and largest
shareholder Richard Jennings, which provides the Company with increased
liquidity as we advance the Company's clear strategic priorities as previously
announced.
"Our near-term capital requirements are targeted and being spent almost
exclusively at the asset level as evidence by the Board's salary deferrals,
and this facility is an important step in supporting ongoing activity across
the business.
"I would like to thank Richard for his continued unwavering support and firm
message of confidence in Kazera's prospects to deliver shareholder value that
this facility represents.
"We remain in discussions with Tracarta and are focused on reaching an
appropriate outcome that supports the Company's ongoing development whilst
delivering value for all shareholders."
Related Party Transaction
Richard Jennings is Interim Chief Executive Officer and a Director of the
Company and is also a substantial shareholder. Accordingly, the extension of
the Existing Loan and the New Facility constitute related party transactions
pursuant to Rule 13 of the AIM Rules for Companies.
The independent Directors consider, having consulted with Strand Hanson
Limited, the Company's nominated adviser, that the terms of the extension are
fair and reasonable insofar as the Company's shareholders are concerned.
For further information, visit www.kazeraglobal.com
(http://www.kazeraglobal.com/) or contact:
Kazera Global plc kazera@stbridespartners.co.uk
Geoff Eyre, Non-Executive Chairman
Strand Hanson Limited (Nominated, Financial Adviser and Broker) Tel: +44 (0)207 409 3494
Christopher Raggett / Ritchie Balmer
Zeus Capital Limited (Joint Broker) Tel: +44 (0)203 829 5000
Harry Ansell / Simon Johnson / Katy Mitchell
St Brides Partners Limited (Financial PR) kazera@stbridespartners.co.uk
Isabel de Salis / Charlotte Page
Notes
Kazera Global plc (LON:KZG) is a diversified commodity investment company
focused on unlocking value through production growth and disciplined portfolio
management. While production builds at its Whale Head Minerals (Heavy Mineral
Sands) and Deep Blue Minerals (diamond) assets in South Africa's Northern Cape
province, the Company also continues to assess new opportunities to expand its
growth pipeline and deliver sustainable returns.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END UPDMZGFDLGZGVZG
Copyright 2019 Regulatory News Service, all rights reserved